Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announced its plans to increase its presence in Walmart.com and ramp up its current offering to over thirty (30) SKUs before the end of the year.
Following the successful initial test launch of three (3) SKUs, the Company is now ready to introduce up to thirty (30) new SKUs of its Bioganix® Gold Series formulated products before the end of this year. The Company has also begun the regulatory and compliance process to launch its formulated products in the Canadian market and plans to test walmart.ca as soon as the products obtain natural health product approvals from Health Canada.
“Following an initial market testing period, we are now expanding our presence in walmart.com to over thirty (30) SKUs and we are targeting walmart.ca platform for the initial launch of the Bioganix® Gold Series brand into the Canadian market” stated Abis Hussain, Chief Marketing Officer.
“We are working through the regulatory process to launch two (2) exclusive science based formulated products into the Canadian market and we are monitoring Walmart’s recently announced intention to explore the cannabis infused market as we see this as a potential platform for our LeefyLyfe® brand for North America” stated Aurelio Useche, Chief Executive Officer
The Company continues to make significant progress in its OTC nutraceutical formulated business and recently announced a line of hemp derived organic CBD infused products under the LeefyLyfe® brand for the European market.
About Relevium Technologies
Relevium is a publicly-traded company that operates in the health and wellness industry, a multi-billion-dollar market worldwide.
Relevium markets its products as dietary
VANCOUVER, British Columbia, Oct. 12, 2018 (GLOBE NEWSWIRE) — Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (the “Company” or “Chemesis”), and Rapid Dose Therapeutics Inc. (“RDT”), a Canadian bio-technology company which provides disruptive proprietary drug delivery technologies designed to improve patient outcomes, are proud to announce they have signed a definitive agreement, providing a Managed Strip Service Agreement enabling Chemesis to produce QuickStrips™ infused with cannabis oils. RDT’s innovative QuickStrip is an easy-to-use, safe and effective oral fast-dissolving drug delivery system, developed in conjunction with McMaster University through the renowned Adronov Research Group, which provides accurate dosing and potency. Under the terms of the agreement, Chemesis will receive rights to produce, distribute and sell QuickStrip products, with rights for cannabis markets in California. With Chemesis’ state-of-the-art facility, the Company believes this partnership with RDT will further strengthen its position in the California cannabis market, by allowing the Company to use a convenient drug delivery system that … Continue reading
Next Green Wave LLC (CSE:NGW) is a vertically integrated company with full seed to consumer capabilities, four conditional use permits for medical and recreational sales, and complete compliance with California’s Medical Marijuana Regulation and Safety Act (“MMRSA”). NGW’s licensing allows for cultivation, nursery, and volatile and non-volatile extraction setting the company up in a strategic position to distribute to the entirety of the rapidly expanding California market as it is listing on the Canadian Securities Exchange (“CSE”) on October 10th, 2018. Next Green Wave’s seed to sale element enables control of the entire growing, manufacturing, sales, and distribution processes under its highly proficient and professional management team who have decades of expertise in the cannabis space. With a focus on genetics and tissue culturing, the group has been developing genetic strains known worldwide as an integral part of the company’s highly decorated brand, Loud Seeds. Loud Seeds is a member … Continue reading
VANCOUVER, Oct. 12, 2018 /CNW/ – Village Farms International, Inc. (“Village Farms” or the “Company“) (TSX: VFF) (OTCQX: VFFIF) announced today that it has completed its previously announced bought deal offering of 3,097,200 common shares (the “Offered Shares“) in the capital of the Company at a price of $7.13 per Offered Share (the “Issue Price“) for aggregate gross proceeds to the Company of $22,083,036 (the “Offering“). The Offering was conducted by a syndicate of underwriters led by Beacon Securities Limited, and including GMP Securities L.P. (collectively, the “Underwriters“). The Offering included 287,200 Offered Shares issued pursuant to a partial exercise of the Underwriters’ over-allotment option. The Company intends to use the net proceeds of the Offering for working capital purposes, which may include funding certain future capital needs of Pure Sunfarms Corp. as well as other growth opportunities that may arise in respect of the Company’s business over time. Further details can be found in the Company’s short … Continue reading
VANCOUVER, Oct. 12, 2018 /PRNewswire/ – 1933 Industries Inc. (the “Company” or “1933 Industries”) (CSE: TGIF) (OTCQB: TGIFF) is pleased to report that its subsidiary, Infused MFG (“Infused”), hit a record year of growth and continues to expand sales of its products in Nevada, California and Colorado. Increasing demand for Infused’s Canna Hemp™ proprietary line of hemp-based, CBD-infused products contributed to the strong revenue growth, which has increased from revenue of US$7,403 in June of 2017 to over US$600,000 per month in just 14 months. This represents an 8,000% increase and supports the company’s projections for the upcoming year, where Infused is forecasted to reach an average of US$1M in revenue per month. With a strong presence throughout the State of Nevada, Infused has established key distribution networks in California, where it now sells its products in over 100 retail shops. In total, Infused boasts over 400 retail locations around the US, with an average of 50 new wholesale accounts added every month. The Company … Continue reading
TORONTO, Oct. 11, 2018 /CNW/ – Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) announced today that it has entered into an agreement with a syndicate of underwriters led by Canaccord Genuity Corp. (the “Lead Underwriter” and, collectively with the syndicate, the “Underwriters”), pursuant to which the Underwriters will purchase, on a bought deal basis pursuant to the filing of a short form prospectus, an aggregate of 30,350,000 units (the “Units”) of the Company at a price of $1.65 per Unit (the “Offering Price”) for aggregate gross proceeds of $50,077,500 (the “Offering”). Each Unit will consist of one common share (a “Common Share”) and one-half of one common share purchase warrant (each full common share purchase warrant, a “Warrant”) of the Company. Each Warrant will be exercisable to acquire one common share of the Company for a period of three years following the Closing Date (as hereinafter defined) at … Continue reading
CFN Media Group (“CFN Media”, “CannabisFN”), the leading agency and financial media network dedicated to the worldwide cannabis industry, today announced the enhanced launch of its Los Angeles-based studio for filming exclusive executive interviews and its CFN Weekly Show. The company soft launched the studio earlier this year, filming exclusive client interviews and early episodes of the CFN Weekly Show. The new studio features green screen technology and a configurable set, which makes it easy for clients to choose a look-and-feel that best suits their vision and brand. “California is becoming the epicenter of the industry and home to the best creative minds in the world,” said CFN Media President Frank Lane. “Our LA studio allows us to produce stunning media and programming that powerfully conveys our clients’ messaging to engaged audiences around the world.” The exclusive interviews filmed at the new studio are part of CFN Media’s client outreach … Continue reading
VANCOUVER, British Columbia, Oct. 11, 2018 (GLOBE NEWSWIRE) — Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (the “Company” or “Chemesis”), is pleased to announce it has reached a fulfillment and distribution agreement for the ultra-premium Julian Marley JuJu Royal™ brand. The packaging, fulfillment and distribution will be for all of JuJu Royal’s Southern California operations. This highly sought-after brand consists of carefully crafted, quality cannabis products that will be handled in the Company’s Desert Zen facility, based in Cathedral City, CA. These products meet Julian Marley’s demanding standards and are currently being sold in multiple states. The catalogue of products includes a variety of cannabis products and signature strains exclusive to JuJu Royal. “The agreement for JuJu Royal is another example of Chemesis’ ability to delivery consistent quality products, validating Management’s business plan and growth strategy,” said CEO, Edgar Montero. “Brands that require high quality services are recognizing our ability to consistently handle full compliance capacity for … Continue reading
VANCOUVER, British Columbia, Oct. 11, 2018 (GLOBE NEWSWIRE) — BlissCo Cannabis Corp. (CSE: BLIS) (OTCQB: HSTRF) (FRA: GQ4B), (“BlissCo”) or the (“Company”) is pleased to announce that it has signed a letter of intent (LOI) to purchase CannaTel Cannabis Corporation (“CannaTel”), which has secured pre-approval for a medical cannabis cultivation license in Israel in partnership with local farmer Mr. Yoel Dub. BlissCo will pay $3,000,000 CAN in BlissCo shares to CannaTel paid in installments tied to specific milestones being met. BlissCo will work in partnership with local farmer Mr. Yoel Dub, who has earned a pre-approval for a medical cannabis production license from Israel’s Ministry of Health. CannaTel’s principals have a sublease agreement with local farmer Mr. Yoel Dub to grow medical cannabis until December 13, 2041 or for 23 years. BlissCo Cannabis Corp., through its wholly owned subsidiary BlissCo Israel R&D Corp. (“BlissCo Israel”), will own the pre-approval license that Mr. … Continue reading
MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQB: MMNFF) (FSE: A2JM6N) and Chicago-based PharmaCann LLC (“PharmaCann”) announced today that both companies have signed a binding letter of intent (the “Agreement”) for MedMen to acquire PharmaCann in an all-stock transaction valued at $682 million. The resulting pro-forma company (including pending acquisitions by MedMen) will have a portfolio of cannabis licenses in 12 states that will permit the combined company to operate 79 cannabis facilities. The combined company will operate in 12 states, which comprise a total estimated addressable market, as of 2030, of approximately $40 billion according to Cowen Group. Through the transaction, MedMen will add licenses in Illinois, New York, Pennsylvania, Maryland, Massachusetts, Ohio, Virginia and Michigan. “This is a transformative acquisition that will create the largest U.S. cannabis company in the world’s largest cannabis market,” said Adam Bierman, MedMen’s chief executive officer and co-founder. “The transaction adds … Continue reading